← World Watch
Disruptionother · July 16, 2026
India bets ₹10,000 crore on a leap from generic drugs to biologics
The headline signals a potential expansion and reshaping of pharmaceutical manufacturing capacity in India toward biologics.
Source →The trace
How it reaches your house.
Starting from the trigger, we walked the supply graph hop by hop to the goods you buy and the companies you own. Each step is the engine’s reasoning, scored for confidence and cited where a source backs it.
The causal trace for this event is still being written.